Rankings
▼
Calendar
TRDA FY 2019 Earnings — Entrada Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TRDA
Entrada Therapeutics, Inc.
$518M
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$104,000
Operating Income
-$12M
Net Income
-$5M
EPS (Diluted)
$-4.44
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$294,000
Balance Sheet
Total Assets
$18M
Total Liabilities
$34M
Stockholders' Equity
-$16M
Cash & Equivalents
$17M
← Q1 2020
All Quarters